Changes in the human immunodeficiency virus p7-p1-p6 gag gene in drug-naive and pretreated patients

被引:29
作者
Gallego, O [1 ]
de Mendoza, C [1 ]
Corral, A [1 ]
Soriano, V [1 ]
机构
[1] Inst Salud Carlos III, Hosp Carlos III, Infect Dis Serv, Madrid, Spain
关键词
D O I
10.1128/JCM.41.3.1245-1247.2003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Resistance to antiretroviral agents often results from mutations within the human immunodeficiency virus (HIV) pol gene. Moreover, insertions within the p6 gag pol region have recently been found to be involved with resistance to nucleoside analogs. Overall, we found that 21% of 156 specimens collected from HIV-infected individuals (17.6% from 74 drug-naive patients and 24.4% from 82 pretreated patients) harbored these insertions. Insertions around the KQE (Lys-Gin-Glu) motif were found in 12.2% of the pretreated patients but in none of the drug-naive subjects (P = 0.002). In contrast, insertions around the PTAP (Prof-Thre-Ala-Prol) motif were seen at similar rates (similar to15%) among drug-naive and pretreated patients, which supports the idea that they may be natural polymorphisms.
引用
收藏
页码:1245 / 1247
页数:3
相关论文
共 17 条
[1]   Polymorphism of HIV type 1 Gag p7/p1 and p1/p6 cleavage sites: Clinical significance and implications for resistance to protease inhibitors [J].
Bally, F ;
Martinez, R ;
Peters, S ;
Sudre, P ;
Telenti, A .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2000, 16 (13) :1209-1213
[2]   Antiretroviral therapy in adults - Updated recommendations of the International AIDS Society-USA Panel [J].
Carpenter, CCJ ;
Cooper, DA ;
Fischl, MA ;
Gatell, JM ;
Gazzard, BG ;
Hammer, SM ;
Hirsch, MS ;
Jacobsen, DM ;
Katzenstein, DA ;
Montaner, JSG ;
Richman, DD ;
Saag, MS ;
Schechter, M ;
Schooley, RT ;
Vella, S ;
Yeni, PG ;
Volberding, PA .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (03) :381-390
[3]   Phenotypic and genotypic resistance patterns of HIV-1 isolates derived from individuals treated with didanosine and stavudine [J].
Coakley, EP ;
Gillis, JM ;
Hammer, SM .
AIDS, 2000, 14 (02) :F9-F15
[4]  
de Mendoza C, 2000, J ACQ IMMUN DEF SYND, V23, P279
[5]  
DECKS S, 2001, J ACQUIR IMMUNE D S1, V26, P25
[6]   Changes in the rate of genotypic resistance to antiretroviral drugs in Spain [J].
Gallego, O ;
Ruiz, L ;
Vallejo, A ;
Ferrer, E ;
Rubio, A ;
Clotet, B ;
Leal, M ;
Soriano, V .
AIDS, 2001, 15 (14) :1894-1896
[7]   Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in Spain [J].
Gomez-Cano, M ;
Rubio, A ;
Puig, T ;
Perez-Olmeda, M ;
Ruiz, L ;
Soriano, V ;
Pineda, JA ;
Zamora, L ;
Xaus, N ;
Clotet, E ;
Leal, M .
AIDS, 1998, 12 (09) :1015-1020
[8]   Antiretroviral drug resistance testing in adult HIV-1 infection -: Recommendations of an International AIDS Society-USA panel [J].
Hirsch, MS ;
Brun-Vézinet, F ;
D'Aquila, RT ;
Hammer, SM ;
Johnson, VA ;
Kuritzkes, DR ;
Loveday, C ;
Mellors, JW ;
Clotet, B ;
Conway, B ;
Demeter, LM ;
Vella, S ;
Jacobsen, DM ;
Richman, DD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (18) :2417-2426
[9]   Impact of HIV type 1 protease, reverse transcriptase, cleavage site, and p6 mutations on the virological response to quadruple therapy with saquinavir, ritonavir, and two nucleoside analogs [J].
Kaufmann, GR ;
Suzuki, K ;
Cunningham, P ;
Mukaide, M ;
Kondo, M ;
Imai, M ;
Zaunders, J ;
Cooper, DA .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2001, 17 (06) :487-497
[10]   Nucleoside reverse transcriptase inhibitor resistance [J].
Loveday, C .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 26 :S10-S24